<DOC>
	<DOCNO>NCT02970643</DOCNO>
	<brief_summary>The purpose study determine whether Palonosetron Olanzapine without dexamethasone Prevention moderate risk Chemotherapy-Induced Nausea vomiting .</brief_summary>
	<brief_title>Proof-of-Concept Trial Palonosetron Olanzapine Without Dexamethasone Prevention CIN</brief_title>
	<detailed_description>This study design evaluate efficacy safety olanzapine compare 5-hydroxytryptamine3 receptor antagonist prevention moderate risk chemotherapy induce nausea vomiting .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<criteria>European Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 severe cognitive compromise Moderate risk chemotherapy induce chemotherapy induce nausea vomit 1st cycle Confirmed histology European Cooperative Oncology Group ( ECOG ) performance status 3 4 Nausea vomit 24 hour enrollment History Nausea vomit Grade 3 previous chemotherapy Known history central nervous system disease ( e.g. , brain metastasis seizure disorder ) Bowel obstruction Serum creatinine level 2.0 mg per deciliter ( 177 Î¼mol per liter ) Aspartate alanine aminotransferase level 3 time upper limit normal range Treatment another antipsychotic agent risperidone , quetiapine , clozapine , phenothiazine , butyrophenone within 30 day enrollment Treatment another antiemetic agent 48 hour enrollment Uncontrolled severe infection uncontrolled severe comorbidity Concurrent abdominal radiotherapy Known hypersensitivity olanzapine , palonosetron Known cardiac arrhythmia , uncontrolled congestive heart failure , acute myocardial infarction within previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Olanzapine</keyword>
	<keyword>Chemotherapy-Induced Nausea Vomiting</keyword>
	<keyword>Moderate risk</keyword>
</DOC>